Alliancebernstein L.P. Theravance Biopharma, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 78,855 shares of TBPH stock, worth $776,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,855

Previous 78,855 -0.0%

Holding current value

$776,721

Previous $668,000 4.94%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $51,563 - $61,702	6,220 Added 8.56%	78,855 $668,000
Q1 2024 May 14, 2024	SELL	$8.22 - $11.59 $41,922 - $59,109	-5,100 Reduced 6.56%	72,635 $651,000
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $1,666 - $2,592	200 Added 0.26%	77,735 $743,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $50,456 - $75,140	6,800 Added 9.61%	77,535 $857,000
Q1 2021 May 06, 2021	SELL	$16.57 - $21.08 $99,420 - $126,479	-6,000 Reduced 7.82%	70,735 $1.44 Million
Q3 2020 Nov 12, 2020	SELL	$14.79 - $22.49 $19,227 - $29,236	-1,300 Reduced 1.67%	76,735 $1.14 Million
Q2 2020 Aug 13, 2020	BUY	$20.64 - $30.69 $278,640 - $414,315	13,500 Added 20.92%	78,035 $1.64 Million
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $5,352 - $9,363	300 Added 0.47%	64,535 $1.49 Million
Q4 2019 Feb 18, 2020	BUY	$16.12 - $25.89 $20,956 - $33,657	1,300 Added 2.07%	64,235 $1.66 Million
Q4 2018 Feb 13, 2019	SELL	$22.52 - $35.07 $15,764 - $24,549	-700 Reduced 1.1%	62,935 $1.61 Million
Q3 2018 Nov 08, 2018	BUY	$22.83 - $32.67 $41,094 - $58,806	1,800 Added 2.91%	63,635 $2.08 Million
Q2 2018 Aug 13, 2018	BUY	$22.06 - $25.52 $48,532 - $56,144	2,200 Added 3.69%	61,835 $1.4 Million
Q1 2018 May 14, 2018	SELL	$23.37 - $29.71 $37,392 - $47,536	-1,600 Reduced 2.61%	59,635 $1.45 Million
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $1.46 Million - $2.14 Million	61,235	61,235 $2.1 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Theravance Biopharma, Inc. Transaction History